We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Biodegradable Plastic Implants for Blood Vessel Repair

By LabMedica International staff writers
Posted on 12 May 2015
Print article
Image: Gross examination of an explanted TPU conduit after six months shows a white shiny inner surface without evidence of clot formation (Photo courtesy of Medical University of Vienna).
Image: Gross examination of an explanted TPU conduit after six months shows a white shiny inner surface without evidence of clot formation (Photo courtesy of Medical University of Vienna).
A new generation of artificial blood vessels gradually degrades as it is replaced by endogenous tissue that restores full biological function.

Investigators at Vienna University of Technology and Vienna Medical University worked with a type of biodegradable plastic known as thermoplastic polyurethane (TPU), which displays the adequate biomechanical strength and wall structure needed to promote rapid host remodeling.

In a study conducted on a group of 34 rats they investigated the in vitro and in vivo biocompatibility of thin host-vessel-matched grafts formed from hard-block biodegradable TPU. Expanded polytetrafluoroethylene (ePTFE) conduits served as control grafts in 34 other rats. Grafts were analyzed by various techniques after retrieval at different time points (one week; 1, 6, 12 months).

Results published in the January 1, 2015, issue of the journal Acta Biomaterialia revealed that TPU grafts showed significantly increased endothelial cell proliferation in vitro. Population by host cells increased significantly in the TPU conduits within one month of implantation. After long-term implantation, all the TPU implants, but only 93% of the ePTFE conduits, were expanded and unblocked with no signs of aneurysmal dilatation. Substantial remodeling of the degradable grafts was observed but varied between subjects. Intimal hyperplasia was found in 29% of the ePTFE conduits but not in the TPU implants.

First author Dr. Helga Bergmeister, professor of surgery at Vienna Medical University, said, "The rats' blood vessels were examined six months after insertion of the vascular prostheses. We did not find any aneurysms, thromboses or inflammation. Endogenous cells had colonized the vascular prostheses and turned the artificial constructs into natural body tissue."

Related Links:

Vienna University of Technology  
Vienna Medical University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.